Is it time to buy shares in Santos Ltd, Healthscope Ltd, and Primary Health Care Limited?

Credit: Valerie Everett

A staggering 122 companies hit new 52-week lows this week, most of them in resources as plunging iron ore and Brent crude oil prices hit producers and service companies for six. Shares in Rio Tinto Limited (ASX: RIO)Beach Energy Ltd (ASX: BPT), and South32 Ltd (ASX: S32) all hit new lows this week.

No surprises there, but a couple of decent companies look to have been thrown out as well:

Santos Ltd (ASX: STO) – last traded at $3.31, down 61% for the year

Let’s get the obvious mention out of the way first. Santos shares have been hammered in the past year because low oil prices have crushed its profits and investors are looking increasingly nervous about the company’s ability to pay its debt.

While a low Australian dollar theoretically provides a good tailwind (since oil is sold in US dollars), Santos’ debt is denominated in USD which mitigates much of the benefit. While Santos shares could experience significant upside when the value of oil recovers, that could take a long time as high-cost producers don’t exit the market overnight – just look at iron ore.

Santos is a speculative investment, and only for buyers with a high risk tolerance. After all, prices could always go lower.

Healthscope Ltd (ASX: HSO) – last traded at $2.48, down 5% for the year

Owned by private equity until recently, private hospital and pathology operator Healthscope has been sold off over investor fears it will turn into the next Dick Smith Holdings Ltd (ASX: DSH) or Spotless Group Holdings Ltd (ASX: SPO).

Shares are down 10% from recent highs and 5% for the year, which is nowhere near enough to mitigate the risks given that Healthscope was highly priced when it debuted and still trades on a price to Earnings (P/E) ratio of 27. Debt is high and Healthscope also faces similar uncertainty to Primary Health (although to a lesser extent) as a result of the government focus on cutting health expenditure.

While it may be a solid business, I feel that there are better companies out there at more attractive prices.

Primary Health Care Limited (ASX: PRY) – last traded at $2.99, down 37% for the year

I wrote on Primary Health at its previous 52-week low in October, where I stated that I was uncomfortable with the company’s high debt load and the potential for an earnings hit in the form of the government’s ongoing productivity review into the healthcare system.

Since that article, shares have fallen another 20% and Primary trades on a P/E of 11, substantially lower than competitors Sonic Health Care Limited (ASX: SHL) and Ramsay Health Care Limited  (ASX: RHC), which have P/Es north of 20 and 30, respectively.

In fact Primary Health looks to be firmly in bargain territory – if you’re comfortable with the above risks.

I’m not, and I believe investors should wait for more information on the company’s future growth plans and the anticipated impacts from the medical system review before buying. Primary has a very poor track record of growing shareholder wealth over the long term and a low price won’t necessarily change that.

Discover our best bet for outstanding income right now

Our resident dividend expert has just named his Top Dividend Stock for 2016. Not only are the shares dirt cheap, the company is trading on a 5.6% fully franked dividend yield. Simply click on the link and enter your email address to gain access to this comprehensive FREE investment report - no credit card details or payment required!

Yep, it's free, and includes the stock's name and code. Just click here now for your copy.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.